Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc. (CRDL) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)

SC 13G/ACRDLFiled Sep 23, 2026, 8:16 AM ET

About this filing

Cardiol Therapeutics Inc. (CRDL) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Sep 23, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More CRDL filings

6-K
SEC filing
Filed Nov 3, 2026
6-K
SEC filing
Filed Nov 3, 2026
SUPPL
SEC filing
Filed Nov 3, 2026
6-K
SEC filing
Filed Sep 23, 2026
SUPPL
SEC filing
Filed Sep 16, 2026
F-10/A
SEC filing (amendment)
Filed Sep 16, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.